Emerging roles for the non-canonical IKKs in cancer

被引：116

作者：

Shen, R. R. ^{[1
]}

Hahn, W. C. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Broad Inst Harvard & MIT, Cambridge, MA USA

来源：

ONCOGENE | 2011年 / 30卷 / 06期

关键词：

NF-kappa B; cancer; IKK; NF-KAPPA-B; INNATE IMMUNE-RESPONSE; KINASE-RELATED KINASES; TUMOR-SUPPRESSOR CYLD; INTERFERON REGULATORY FACTOR-3; UBIQUITIN-LIKE DOMAIN; BREAST-CANCER; I INTERFERON; ANTIVIRAL RESPONSE; ADAPTER PROTEIN;

D O I：

10.1038/onc.2010.493

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The I kappa B Kinase (IKK)-related kinases TBK1 and IKK epsilon have essential roles as regulators of innate immunity by modulating interferon and NF-kappa B signaling. Recent work has also implicated these non-canonical IKKs in malignant transformation. IKK epsilon is amplified in similar to 30% of breast cancers and transforms cells through the activation of NF-kappa B. TBK1 participates in RalB-mediated inflammatory responses and cell survival, and is essential for the survival of non-small cell lung cancers driven by oncogenic KRAS. The delineation of target substrates and downstream activities for TBK1 and IKK epsilon has begun to define their role(s) in promoting tumorigenesis. In this review, we will highlight the mechanisms by which IKKe and TBK1 orchestrate pathways involved in inflammation and cancer. Oncogene (2011) 30, 631-641; doi:10.1038/onc.2010.493; published online 1 November 2010

引用

页码：631 / 641

页数：11

共 112 条

[11] The landscape of somatic copy-number alteration across human cancers [J].

Beroukhim, Rameen ;

Mermel, Craig H. ;

Porter, Dale ;

Wei, Guo ;

Raychaudhuri, Soumya ;

Donovan, Jerry ;

Barretina, Jordi ;

Boehm, Jesse S. ;

Dobson, Jennifer ;

Urashima, Mitsuyoshi ;

Mc Henry, Kevin T. ;

Pinchback, Reid M. ;

Ligon, Azra H. ;

Cho, Yoon-Jae ;

Haery, Leila ;

Greulich, Heidi ;

Reich, Michael ;

Winckler, Wendy ;

Lawrence, Michael S. ;

Weir, Barbara A. ;

Tanaka, Kumiko E. ;

Chiang, Derek Y. ;

Bass, Adam J. ;

Loo, Alice ;

Hoffman, Carter ;

Prensner, John ;

Liefeld, Ted ;

Gao, Qing ;

Yecies, Derek ;

Signoretti, Sabina ;

Maher, Elizabeth ;

Kaye, Frederic J. ;

Sasaki, Hidefumi ;

Tepper, Joel E. ;

Fletcher, Jonathan A. ;

Tabernero, Josep ;

Baselga, Jose ;

Tsao, Ming-Sound ;

Demichelis, Francesca ;

Rubin, Mark A. ;

Janne, Pasi A. ;

Daly, Mark J. ;

Nucera, Carmelo ;

Levine, Ross L. ;

Ebert, Benjamin L. ;

Gabriel, Stacey ;

Rustgi, Anil K. ;

Antonescu, Cristina R. ;

Ladanyi, Marc ;

Letai, Anthony .

NATURE, 2010, 463 (7283) :899-905

[12] Involvement of the IκB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation [J].

Bibeau-Poirier, Annie ;

Gravel, Simon-Pierre ;

Clement, Jean-Francois ;

Rolland, Sebastien ;

Rodier, Genevieve ;

Coulombe, Philippe ;

Hiscott, John ;

Grandvaux, Nathalie ;

Meloche, Sylvain ;

Servant, Marc J. .

JOURNAL OF IMMUNOLOGY, 2006, 177 (08) :5059-5067

[13] NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis [J].

Biswas, DK ;

Shi, Q ;

Baily, S ;

Strickland, I ;

Ghosh, S ;

Pardee, AB ;

Iglehart, JD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (27) :10137-10142

[14] Ral GTPases and cancer: linchpin support of the tumorigenic platform [J].

Bodemann, Brian O. ;

White, Michael A. .

NATURE REVIEWS CANCER, 2008, 8 (02) :133-140

[15] Integrative genomic approaches identify IKBKE as a breast cancer oncogene [J].

Boehm, Jesse S. ;

Zhao, Jean J. ;

Yao, Jun ;

Kim, So Young ;

Firestein, Ron ;

Dunn, Ian F. ;

Sjostrom, Sarah K. ;

Garraway, Levi A. ;

Weremowicz, Stanislawa ;

Richardson, Andrea L. ;

Greulich, Heidi ;

Stewart, Carly J. ;

Mulvey, Laura A. ;

Shen, Rhine R. ;

Ambrogio, Lauren ;

Hirozane-Kishikawa, Tomoko ;

Hill, David E. ;

Vidal, Marc ;

Meyerson, Matthew ;

Grenier, Jennifer K. ;

Hinkle, Greg ;

Root, David E. ;

Roberts, Thomas M. ;

Lander, Eric S. ;

Polyak, Kornelia ;

Hahn, William C. .

CELL, 2007, 129 (06) :1065-1079

[16] The two NF-κB activation pathways and their role in innate and adaptive immunity [J].

Bonizzi, G ;

Karin, M .

TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288

[17] Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription [J].

Bonnard, M ;

Mirtsos, C ;

Suzuki, S ;

Graham, K ;

Huang, JN ;

Ng, M ;

Itié, A ;

Wakeham, A ;

Shahinian, A ;

Henzel, WJ ;

Elia, AJ ;

Shillinglaw, W ;

Mak, TW ;

Cao, ZD ;

Yeh, WC .

EMBO JOURNAL, 2000, 19 (18) :4976-4985

[18] STATs in oncogenesis [J].

Bowman, T ;

Garcia, R ;

Turkson, J ;

Jove, R .

ONCOGENE, 2000, 19 (21) :2474-2488

[19] Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].

Brummelkamp, TR ;

Nijman, SMB ;

Dirac, AMG ;

Bernards, R .

NATURE, 2003, 424 (6950) :797-801

[20] Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription [J].

Buss, H ;

Dörrie, A ;

Schmitz, ML ;

Hoffmann, E ;

Resch, K ;

Kracht, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55633-55643

← 1 2 3 4 5 6 7 8 9 10 →